Journal of Dermatology最新文献

筛选
英文 中文
Development of Descending Thoracic Aortic Aneurysm in a Psoriasis Patient Under Guselkumab Treatment 在Guselkumab治疗下银屑病患者胸降主动脉瘤的发展。
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-05 DOI: 10.1111/1346-8138.70107
Chiharu Nomura, Tomomitsu Miyagaki, Shinya Oba, Ken Go, Takafumi Kadono, Hidenori Watabe
{"title":"Development of Descending Thoracic Aortic Aneurysm in a Psoriasis Patient Under Guselkumab Treatment","authors":"Chiharu Nomura, Tomomitsu Miyagaki, Shinya Oba, Ken Go, Takafumi Kadono, Hidenori Watabe","doi":"10.1111/1346-8138.70107","DOIUrl":"10.1111/1346-8138.70107","url":null,"abstract":"","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"e155-e156"},"PeriodicalIF":2.7,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study 52例食管黑色素瘤的手术和ICI治疗结果:一项回顾性单中心队列研究
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-05 DOI: 10.1111/1346-8138.70097
Akihiro Ishiguro, Dai Ogata, Koshiro Ishiyama, Junya Oguma, Daisuke Kurita, Eiji Nakano, Kenjiro Namikawa, Akira Takahashi, Hiroyuki Daiko, Yasuyuki Seto, Naoya Yamazaki
{"title":"Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study","authors":"Akihiro Ishiguro,&nbsp;Dai Ogata,&nbsp;Koshiro Ishiyama,&nbsp;Junya Oguma,&nbsp;Daisuke Kurita,&nbsp;Eiji Nakano,&nbsp;Kenjiro Namikawa,&nbsp;Akira Takahashi,&nbsp;Hiroyuki Daiko,&nbsp;Yasuyuki Seto,&nbsp;Naoya Yamazaki","doi":"10.1111/1346-8138.70097","DOIUrl":"10.1111/1346-8138.70097","url":null,"abstract":"<div>\u0000 \u0000 <p>Primary malignant melanoma of the esophagus (PMME) accounts for only 0.5% of all melanomas but is associated with the shortest interval to disease progression and the highest metastasis rate. The optimal treatment for PMME remains elusive. The present study aimed to assess the utility of screening as a means of predicting the prognosis of PMME and to determine the efficacy of surgery and immune checkpoint inhibitors (ICIs) against this disease. Fifty-two patients with PMME treated at the National Cancer Center Hospital in Japan between 2010 and 2023 were enrolled. Survival analysis was performed for (i) patients with PMME (<i>n</i> = 52); (ii) resectable cases at the initial presentation (<i>n</i> = 36); and (iii) cases with systemic therapy (<i>n</i> = 37). The 5-year overall survival (OS) rate was 45.0%, and the median OS was 55.8 months. The 5-year OS rate of the patients in whom PMME was detected by screening and those in whom it was diagnosed clinically was 54.7% and 40.1%, respectively (<i>p</i> = 0.255). The presence of a lymph node metastasis was associated with a significantly higher recurrence and poorer prognosis. The 3-year RFS rate of the patients at the local and nodal stage was 57.8% and 6.9%, respectively (<i>p</i> &lt; 0.0001). At surgery, the rate of lymph node metastasis in the recurrence group and the nonrecurrence group was 68% and 10%, respectively (<i>p</i> = 0.0027). In the patients who received ICI therapy, the 3-year OS was 33.3%, the median OS was 15.0 months, and the overall response rate was 23.5%. Our findings suggested that ICI therapy may improve survival in patients with advanced PMME. However, further research is warranted to identify both the clinical and molecular predictors of the treatment response as a means of improving patient selection.</p>\u0000 </div>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"264-272"},"PeriodicalIF":2.7,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Melanoma Pathology Report: What to Expect and How to Interpret It 黑素瘤病理报告:期待什么和如何解释它。
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-03 DOI: 10.1111/1346-8138.70071
Alexander Nirenberg, Richard Williams, Howard Steinman, Stuart Anderson, Anthony Dixon
{"title":"The Melanoma Pathology Report: What to Expect and How to Interpret It","authors":"Alexander Nirenberg,&nbsp;Richard Williams,&nbsp;Howard Steinman,&nbsp;Stuart Anderson,&nbsp;Anthony Dixon","doi":"10.1111/1346-8138.70071","DOIUrl":"10.1111/1346-8138.70071","url":null,"abstract":"<div>\u0000 \u0000 <p>Pathological information is critical to patient management in melanoma. A uniform approach based on current evidence is crucial and is summarized in this paper. Essential clinical and pathological parameters to report are the BAUSSS biomarker prognostic criteria, that is, Breslow thickness, patient age, presence of ulceration, melanoma subtype, patient sex, and anatomic site. Other important parameters to include are adnexal and periadnexal extension, tumor infiltrating lymphocytes, intravascular and abluminal lymphovascular invasion, microsatellites, in-transit metastases, perineural invasion, and margins. Additional parameters that have been recommended for inclusion are mitotic activity, regression, association with nevi and atypical melanocytic hyperplasia. The significance of special stains and genetic studies is also discussed.</p>\u0000 </div>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 1","pages":"3-13"},"PeriodicalIF":2.7,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145672982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solar Urticaria-Like Symptoms Induced by Conjugated Estrogen 偶联雌激素诱导的太阳性荨麻疹样症状
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-01 DOI: 10.1111/1346-8138.70089
Megumi Mizawa, Teruhiko Makino, Chieko Inami, Fumina Furukawa, Tadamichi Shimizu
{"title":"Solar Urticaria-Like Symptoms Induced by Conjugated Estrogen","authors":"Megumi Mizawa,&nbsp;Teruhiko Makino,&nbsp;Chieko Inami,&nbsp;Fumina Furukawa,&nbsp;Tadamichi Shimizu","doi":"10.1111/1346-8138.70089","DOIUrl":"10.1111/1346-8138.70089","url":null,"abstract":"&lt;p&gt;Conjugated estrogens prescribed for menopausal symptoms and osteoporosis prevention are composed of water-soluble estrogen sulfate salts. Although their common adverse effects are well known, photosensitive reactions are rare. We herein report a patient who developed solar urticaria-like symptoms during long-term treatment with conjugated estrogens, with complete resolution of symptoms following drug withdrawal.&lt;/p&gt;&lt;p&gt;A 63-year-old woman presented with a 3-month history of facial erythema that appeared within minutes of exposure to sunlight. She experienced tingling and burning without itching and was unresponsive to antihistamines. As examination 30 min after sun exposure revealed erythema on the nose, cheeks, and ears (Figure 1a), that resolved within 30 min indoors. No blistering, scarring, skin fragility, or hypertrichosis was noted. The patient had been taking conjugated estrogen (Premarin) for 10 years and did not consume alcohol.&lt;/p&gt;&lt;p&gt;Laboratory tests revealed mild liver dysfunction and slightly elevated urinary uroporphyrin and coproporphyrin levels (50 and 172 μg/g Cre, respectively; normal: 2–25 and 8–168). Her urine exhibited pale pink fluorescence under Wood's lamp (Figure 1b). Phototesting revealed minimal erythema doses (MEDs) for ultraviolet (UV) A (&gt; 10 J/cm&lt;sup&gt;2&lt;/sup&gt;) and UVB (60 mJ/cm&lt;sup&gt;2&lt;/sup&gt;), consistent with Fitzpatrick skin type III. Visible light exposure using an automatic slide projector (Cabin Industrial Co.; CS-30PX) for 10 min at 7.5 cm induced erythema without wheal formation or itching (Figure 1c) that resolved within 60 min. No reaction occurred with exposure to UVA, UVB, or hot water. The patient was diagnosed with solar urticaria-like symptoms. After discontinuing conjugated estrogen, both her symptoms and laboratory abnormalities resolved within 3 months, and repeat phototesting showed no abnormal reactions. No recurrence was observed during the 1-year follow-up period, suggesting a causal relationship between estrogen therapy and photosensitivity.&lt;/p&gt;&lt;p&gt;The patient developed solar urticaria-like symptoms that completely resolved after discontinuation of the conjugated estrogen. Typical classical solar urticaria presents with wheals and flare reactions within minutes of sun exposure. However, our patient only developed transient erythema without wheals or itching, indicating an atypical urticarial response. Solar urticaria has occasionally been associated with photodermatoses such as polymorphous light eruptions and porphyria cutanea tarda (PCT) [&lt;span&gt;1&lt;/span&gt;]. Interestingly, estrogens have been implicated in several photosensitive disorders, including hepatic porphyria and polymorphous light-eruption-like dermatosis [&lt;span&gt;2&lt;/span&gt;]. Furthermore, diethylstilbestrol, a synthetic estrogen, has been shown to increase porphyrin accumulation by activating aminolevulinic acid synthase [&lt;span&gt;3&lt;/span&gt;]. Although the precise mechanism remains unclear, estrogen may induce photosensitivity through hepatocell","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"e131-e132"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intra-Arterial Infusion Chemotherapy and Radiotherapy for Right Axillary Advanced Basal Cell Carcinoma Treatment 动脉灌注化疗与放疗治疗右腋窝晚期基底细胞癌。
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-01 DOI: 10.1111/1346-8138.70095
Harutaka Seshimo, Kenichiro Mae, Akihiro Ishiguro, Ryokichi Irisawa, Tatsuhiko Zama, Dai Ogata, Kazutoshi Harada
{"title":"Intra-Arterial Infusion Chemotherapy and Radiotherapy for Right Axillary Advanced Basal Cell Carcinoma Treatment","authors":"Harutaka Seshimo,&nbsp;Kenichiro Mae,&nbsp;Akihiro Ishiguro,&nbsp;Ryokichi Irisawa,&nbsp;Tatsuhiko Zama,&nbsp;Dai Ogata,&nbsp;Kazutoshi Harada","doi":"10.1111/1346-8138.70095","DOIUrl":"10.1111/1346-8138.70095","url":null,"abstract":"","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"e139-e140"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tinea Nigra
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-01 DOI: 10.1111/1346-8138.70094
Yang Bei-bei, Xiao Hua
{"title":"Tinea Nigra","authors":"Yang Bei-bei,&nbsp;Xiao Hua","doi":"10.1111/1346-8138.70094","DOIUrl":"10.1111/1346-8138.70094","url":null,"abstract":"","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"e102-e103"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathogenesis of Vitiligo: Integrating Immune and Non-Immune Cell Crosstalk 白癜风的发病机制:免疫和非免疫细胞串扰的整合。
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-01 DOI: 10.1111/1346-8138.70067
Shintaro Inoue
{"title":"Pathogenesis of Vitiligo: Integrating Immune and Non-Immune Cell Crosstalk","authors":"Shintaro Inoue","doi":"10.1111/1346-8138.70067","DOIUrl":"10.1111/1346-8138.70067","url":null,"abstract":"<p>Vitiligo is an acquired autoimmune disease characterized by depigmented macules resulting from melanocyte loss. It is a complex multifactorial disorder in which genetic predisposition is combined with environmental factors; however, its detailed etiology remains unclear. Although Janus kinase (JAK) inhibitors have recently emerged as a therapeutic option, the range of available molecularly targeted drugs is limited compared to those for atopic dermatitis or psoriasis, necessitating an urgent elucidation of its pathogenesis. The pathogenesis of vitiligo is centrally mediated by cytotoxic CD8<sup>+</sup> T cells (CTLs) specific for melanocyte antigens and their production of interferon-gamma (IFN-γ). In recent years, however, the involvement of other immune cells, such as resident memory T cells and regulatory T cells, innate immune cells, and non-immune cells including keratinocytes and fibroblasts has also garnered attention. Furthermore, pathogenic alterations are also present in clinically normal-appearing non-lesional skin, indicating that this tissue is “primed” for disease development. This finding supports a paradigm shift toward viewing vitiligo as a systemic disease rather than a localized skin disorder. Herein, this review summarizes the current knowledge on the factors leading to the onset and progression of non-segmental vitiligo, while also briefly addressing segmental vitiligo.</p>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"188-199"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12877989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Annular Elastolytic Giant Cell Granuloma With Elevated Serum ACE and Lysozyme: Photoprotection as a Key Strategy for Disease Control 血清ACE和溶菌酶升高的环状弹性溶解性巨细胞肉芽肿:光保护是疾病控制的关键策略。
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-01 DOI: 10.1111/1346-8138.70088
Shiomi Iwata, Saori Takamura, Tomoo Fukuda
{"title":"Annular Elastolytic Giant Cell Granuloma With Elevated Serum ACE and Lysozyme: Photoprotection as a Key Strategy for Disease Control","authors":"Shiomi Iwata,&nbsp;Saori Takamura,&nbsp;Tomoo Fukuda","doi":"10.1111/1346-8138.70088","DOIUrl":"10.1111/1346-8138.70088","url":null,"abstract":"","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"e128-e130"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene 多灶性静脉畸形伴TEK基因两种体细胞致病变异1例。
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-12-01 DOI: 10.1111/1346-8138.70078
Sawako Ochiai, Hiroto Ono, Akira Shimizu, Sumihito Togi, Hiroki Ura, Yo Niida
{"title":"A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene","authors":"Sawako Ochiai,&nbsp;Hiroto Ono,&nbsp;Akira Shimizu,&nbsp;Sumihito Togi,&nbsp;Hiroki Ura,&nbsp;Yo Niida","doi":"10.1111/1346-8138.70078","DOIUrl":"10.1111/1346-8138.70078","url":null,"abstract":"<div>\u0000 \u0000 <p>Multifocal venous malformation (VM) is a rare vascular disorder characterized by multiple cutaneous and visceral venous malformations caused by somatic variants in the <i>TEK</i> gene, which encodes the TIE2 receptor. We report a 30-year-old man presenting with multiple subcutaneous nodules and oral lesions. MRI revealed multiple masses around the left scapula. A biopsy from a lumbar lesion showed dilated venous channels, and immunohistochemistry was positive for CD31. There was no evidence of anemia. Genetic analysis using next-generation sequencing of both skin and blood identified two somatic <i>TEK</i> variants, p.(Tyr897Cys) and p.(Arg918His), restricted to the lesion tissue. Bulk phasing analysis revealed that Y897C and R918H existed both as single variants and as double variants in cis. The absence of these variants in blood confirmed their somatic origin. Based on clinical and pathological findings, the patient was diagnosed with multifocal VM. Clinically, this case resembled multifocal sporadic VM; however, the genetic profile was consistent with blue rubber bleb nevus syndrome, suggesting this case may represent an intermediate phenotype between the two entities. The involvement of the PI3K/AKT/mTOR signaling pathway implies potential therapeutic benefit from mTOR inhibitors, such as sirolimus. Close follow-up is ongoing due to progressive oral involvement.</p>\u0000 </div>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"314-317"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145656646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lichen Nitidus in a Patient With Systemic Sarcoidosis 系统性结节病患者的黑斑地衣。
IF 2.7 3区 医学
Journal of Dermatology Pub Date : 2025-11-28 DOI: 10.1111/1346-8138.70087
Mai Endo, Toshiyuki Yamamoto
{"title":"Lichen Nitidus in a Patient With Systemic Sarcoidosis","authors":"Mai Endo,&nbsp;Toshiyuki Yamamoto","doi":"10.1111/1346-8138.70087","DOIUrl":"10.1111/1346-8138.70087","url":null,"abstract":"","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"53 2","pages":"e126-e127"},"PeriodicalIF":2.7,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书